Sotera Health Q4 revenue beats expectations on sterigenics segment's growth

Sotera Health

24/02/2026 12:18

Overview

Sterilization solutions provider's Q4 revenue grew 4.6%, beating analyst expectations

Adjusted EPS for Q4 increased by $0.05 from the previous year

Company forecasts 2026 net revenue growth of 5.0% to 6.5%

Outlook

Sotera Health projects 2026 net revenues between $1.233 bln and $1.251 bln

Company expects 2026 adjusted EBITDA between $632 mln and $641 mln

Sotera Health forecasts 2026 adjusted EPS in the range of $0.93 to $1.01

Result Drivers

STERIGENICS PERFORMANCE - Sterigenics achieved strong Q4 revenue growth of 10.6%, driven by favorable pricing and volume/mix, partially offset by inflation

NORDION CHALLENGES - Nordion's Q4 revenue decreased 12.3% due to timing of cobalt-60 harvest schedules, impacting volume/mix

NELSON LABS GROWTH - Nelson Labs Q4 revenue increased 2.3%, driven by core lab testing services and favorable pricing

Company press release: ID:nGNX7q133T

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q4 Revenue
Beat
$303.44 mln
$299.51 mln (9 Analysts)
Q4 Net Income
$34.85 mln
Q4 Pretax Profit
Miss
$70.50 mln
$96.45 mln (8 Analysts)
Q4 Gross Profit
$165.92 mln


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the healthcare facilities & services peer group is "buy"

Wall Street's median 12-month price target for Sotera Health Co is $20.00, about 14.4% above its February 23 closing price of $17.49

The stock recently traded at 19 times the next 12-month earnings vs. a P/E of 19 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)